How to Get Cometriq (Cabozantinib) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization & Appeals Guide
Answer Box: Getting Cometriq Covered by UnitedHealthcare in North Carolina
UnitedHealthcare requires prior authorization for Cometriq (cabozantinib capsules) in North Carolina, primarily for progressive, metastatic medullary thyroid cancer (MTC). Submit PA through your oncologist via the UHC Provider Portal with pathology reports, imaging showing progression, and ICD-10 codes. If denied,